Molecular classification of patients with malignant melanoma for new therapeutic strategies

J Clin Oncol. 2007 Jun 1;25(16):e20-1. doi: 10.1200/JCO.2007.11.0965.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Combined Modality Therapy
  • Dacarbazine / administration & dosage*
  • Extracellular Signal-Regulated MAP Kinases / physiology
  • Humans
  • Melanoma / drug therapy*
  • Oligonucleotides, Antisense / administration & dosage*
  • Proto-Oncogene Proteins c-bcl-2 / antagonists & inhibitors
  • Proto-Oncogene Proteins c-bcl-2 / genetics
  • Signal Transduction
  • Skin Neoplasms / drug therapy*
  • Thionucleotides / administration & dosage*

Substances

  • Oligonucleotides, Antisense
  • Proto-Oncogene Proteins c-bcl-2
  • Thionucleotides
  • Dacarbazine
  • oblimersen
  • Extracellular Signal-Regulated MAP Kinases